SCHEMBL2883985

SCHEMBL2883985

Cc1cc(-c2cc(C(F)(F)F)nn2CC(F)(F)F)ccc1N1C(=O)c2cccc(I)c2C1=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYMS P04818 1/20 0.36
LMNA P02545 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HDAC3 O15379 2/20 0.33
HDAC4 P56524 2/20 0.33
HDAC1 Q13547 2/20 0.33
HDAC7 Q8WUI4 2/20 0.33
HDAC2 Q92769 2/20 0.33
HDAC10 Q969S8 2/20 0.33
HDAC11 Q96DB2 2/20 0.33
HDAC8 Q9BY41 2/20 0.33
HDAC6 Q9UBN7 2/20 0.33
HDAC9 Q9UKV0 2/20 0.33
HDAC5 Q9UQL6 2/20 0.33
NCOR2 Q9Y618 2/20 0.33
GRM4 Q14833 6/20 0.33
GRM1 Q13255 5/20 0.33
NR3C1 P04150 3/20 0.33
PGR P06401 3/20 0.33
NR3C2 P08235 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2889793 0.84 PTGS1 (0.35) TYMSLMNASMN1; SMN2GRM4GRM1
SCHEMBL1835277 0.81 GRIA2 (0.39) LMNASMN1; SMN2HDAC3HDAC4HDAC1
SCHEMBL2889755 0.79 LMNA (0.33) LMNASMN1; SMN2GRM4GRM1
SCHEMBL2889814 0.77 LMNA (0.33) LMNASMN1; SMN2GRM4GRM1
SCHEMBL2884223 0.76 PTGS1 (0.37) TYMSLMNASMN1; SMN2GRM4GRM1
SCHEMBL2889349 0.76 AVPR2 (0.33) LMNASMN1; SMN2GRM4GRM1
SCHEMBL2884136 0.76 LMNA (0.36) TYMSLMNASMN1; SMN2GRM4GRM1
SCHEMBL2889412 0.76 TP53 (0.41) TYMSLMNASMN1; SMN2GRM4GRM1
SCHEMBL2883863 0.74 MAPT (0.38) TYMSLMNASMN1; SMN2GRM4GRM1
SCHEMBL2889335 0.74 HTR7 (0.46) TYMSLMNASMN1; SMN2HDAC6GRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100130743-A1 HETEROCYCLE-SUBSTITUTED, N-PHENYL-PHTHALAMIDE DERIVATIVES, RELATED COMPOUNDS AND THEIR USE AS INSECTICIDES BAYER CROPSCIENCE AG (DE) 2010-05-27 US disclosed
US-7674807-B2 Heterocycle-substituted n-phenyl-phthalamide derivatives, related compounds and their use as insecticides BAYER CROPSCIENCE AG (DE) 2010-03-09 US disclosed
US-20070299085-A1 N1-((Pyrazol-1-Ymethyl)-2-Methylphenyl)-Phatalamide Derivatives And Related Compounds Insecticides BAYER CROPSCIENCE AG (DE) 2007-12-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100130743-A1 HETEROCYCLE-SUBSTITUTED, N-PHENYL-PHTHALAMIDE DERIVATIVES, RELATED COMPOUNDS AND THEIR USE AS INSECTICIDES DDT, SQOR, CYP2S1 TYMS 3137/4885LMNA 1336/4885SMN1; SMN2 1140/4885
US-20070299085-A1 N1-((Pyrazol-1-Ymethyl)-2-Methylphenyl)-Phatalamide Derivatives And Related Compounds Insecticides CHRM1, KCNH1, DDT TYMS 460/4885LMNA 1631/4885SMN1; SMN2 840/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.